Anna Sandström Gerdtsson

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Weidong Ma · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
2. Huaqiang Ouyang · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
3. Donglin Liu · 2 shared papers, 2023 · strength 0.40
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
4. Zhanyu Pan · 1 shared paper, 2023 · strength 0.22
   • Paper Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastase… DOI 10.1080/17474124.2023.2183497↗
5. Zhuchen Yan · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
6. Ping Chen · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
7. Tongguo Si · 1 shared paper, 2023 · strength 0.18
   • Paper Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cance… DOI 10.1016/j.clcc.2022.10.007↗
8. Christer Wingren · 3 shared papers, 2012–2016 · strength 0.14
   • Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
   • Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
   • Paper Identification of serum biomarker signatures associated with pancreatic cancer. DOI 10.1158/0008-5472.can-11-2883↗
9. Carl A.K. Borrebaeck · 3 shared papers, 2012–2016 · strength 0.14
   • Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
   • Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
   • Paper Identification of serum biomarker signatures associated with pancreatic cancer. DOI 10.1158/0008-5472.can-11-2883↗
10. Jihui Hao · 1 shared paper, 2016 · strength 0.06
    • Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
11. He Ren · 1 shared paper, 2016 · strength 0.06
    • Paper Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis. DOI 10.1016/j.molonc.2016.07.001↗
12. Núria Malats Riera · 1 shared paper, 2015 · strength 0.05
    • Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
13. Miquel S. Porta · 1 shared paper, 2015 · strength 0.05
    • Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
14. Francisco X. Real · 1 shared paper, 2015 · strength 0.05
    • Paper A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2015/587250↗
15. Roland E. Andersson · 1 shared paper, 2012 · strength 0.03
    • Paper Identification of serum biomarker signatures associated with pancreatic cancer. DOI 10.1158/0008-5472.can-11-2883↗
16. Matthias J. Löhr · 1 shared paper, 2012 · strength 0.03
    • Paper Identification of serum biomarker signatures associated with pancreatic cancer. DOI 10.1158/0008-5472.can-11-2883↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.